The diagnosis of tuberculosis is difficult. The organism grows slowly and is typically not abundantly present in infected organs or tissues. Diagnoses based on direct microscopy are often false negative despite the presence of Mycobacterium tuberculosis. Culturing the organism takes time and, therefore, does not yield a diagnosis within a time frame that is convenient for the clinician who has to make a decision regarding the treatment of a patient with suspected tuberculosis.
In addition to the traditional methods of making the diagnosis, molecular tools have become available and are widely used. Their application has resulted in the improved sensitivity of diagnostic approaches for various clinical scenarios and various infected organs. Nevertheless, these molecular methods also have their shortcomings and are not available throughout the world.
The diagnosis of latent tuberculosis has relied on PPD skin testing and the exclusion of active disease. However, a positive PPD skin test does not enable the clinician to make a differential diagnosis of active versus latent tuberculosis. More recently, immune diagnosis of tuberculosis has been enhanced by the availability of T cellbased assays. These assays have been studied in various settings, including patients with immune suppression. A case with CNS tuberculosis is reported in this issue of Infection [1] . In this patient, a T cell interferon-c release assay was used on cerebral spinal fluid mononuclear cells to speed up the diagnosis of CNS tuberculosis. The issue of local immunodiagnosis is further discussed in a case of diagnosis from pericardial fluid using another type of T cell-based assay [2] . A minireview by Christoph Lange summarizes the current state of knowledge on the usefulness of T cell-based assays for the local diagnosis of tuberculosis from body fluids [3] .
